SU-014813
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SU-014813, covering 2011-05-17 to 2011-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer [Phase 2]